KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Depreciation and Depletion: 2015-2025

Historic Depreciation and Depletion for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $35.7 million.

  • BeOne Medicines' Depreciation and Depletion fell 48.98% to $35.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.2 million, marking a year-over-year increase of 5.40%. This contributed to the annual value of $166.9 million for FY2024, which is 107.54% up from last year.
  • Latest data reveals that BeOne Medicines reported Depreciation and Depletion of $35.7 million as of Q3 2025, which was up 19.68% from $29.9 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Depreciation and Depletion peaked at $70.0 million during Q3 2024, and registered a low of $9.4 million during Q1 2021.
  • For the 3-year period, BeOne Medicines' Depreciation and Depletion averaged around $31.3 million, with its median value being $24.1 million (2024).
  • As far as peak fluctuations go, BeOne Medicines' Depreciation and Depletion skyrocketed by 263.93% in 2024, and later tumbled by 48.98% in 2025.
  • BeOne Medicines' Depreciation and Depletion (Quarterly) stood at $12.3 million in 2021, then spiked by 38.57% to $17.0 million in 2022, then climbed by 22.38% to $20.9 million in 2023, then skyrocketed by 135.10% to $49.0 million in 2024, then crashed by 48.98% to $35.7 million in 2025.
  • Its Depreciation and Depletion was $35.7 million in Q3 2025, compared to $29.9 million in Q2 2025 and $31.6 million in Q1 2025.